Project Search Results

Select

Research Categorization

Operator
Operator

Project Details

Operator
Operator

Contact Researcher and Awardee Organization

Operator
Operator

Funding Organization

Operator
Operator
Operator
Operator
ListGraphMap
Displaying 1 - 10 of 41 Projects
Project # Contact PI Funding Organization Fiscal Year
Validation of the Retinal Deep Phenotyping (TM) platform for the detection of the likely cerebral amyloid status to aid in the diagnosis of Alzheimer's disease
ADDF-31 Sylvestre, Jean-Philippe Alzheimer's Drug Discovery Foundation 2021
Fixational eye motion as biomarker for mild cognitive impairment
ADDF-45 Sheehy, Christy Alzheimer's Drug Discovery Foundation 2021
Development of a Biosample Database to Investigate Beta-Amyloid, Phospho-Tau, and Neurofilament Light Chain Blood-Based and Digital Biomarkers in Older Volunteers Screened for Preclinical AD, Prodromal AD, or Mild AD
ADDF-47 Beauregard, Doug Alzheimer's Drug Discovery Foundation 2021
Integration of multiple digital technologies for the early detection of neurodegenerative diseases
ADDF-51 Kourtzi, Zoe Alzheimer's Drug Discovery Foundation 2021
Molecular neuroimaging of PIPK1/Necroptosis in Alzheimer's disease
ADDF-21 Zhang, Martin Alzheimer's Drug Discovery Foundation 2020
Pre-competitive Analytical Validation of SV2A PET as a Biomarker of Synaptic Density Project
ADDF-6 Horton, Wesley Alzheimer's Drug Discovery Foundation 2020
Identifying an ophthalmic combinatorial biomarker of early Alzheimer's disease using novel imaging and deep learning
ADDF-8 Lee, Cecilia Alzheimer's Drug Discovery Foundation 2020
Alzheimer's Disease Neuroimaging Initiative (ADNI) 3 - Amyloid PET Early Frames Add-on Study
GC-201810-2017396 Canet-Aviles, Rosa Alzheimer's Drug Discovery Foundation 2019
Human PET Imaging Evaluations of the Astroglial L-Glutamate EAAT2 Tracer for Alzheimer’s Disease and Related Dementias
GC-201810-2017455 Gerdes, John Alzheimer's Drug Discovery Foundation 2019
Retinal Changes in Alzheimer’s disease (AD) Correlated with Cerebral Amyloid Staging, A Promising Early Biomarker in AD
GDAPB-201807-2015702 Shaked, Eliav Alzheimer's Drug Discovery Foundation 2019